[1]刘 枫.IgA肾病与系膜增生性肾炎临床特征的比较[J].医学信息,2019,32(16):95-96.[doi:10.3969/j.issn.1006-1959.2019.16.029]
 LIU Feng.Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis[J].Journal of Medical Information,2019,32(16):95-96.[doi:10.3969/j.issn.1006-1959.2019.16.029]
点击复制

IgA肾病与系膜增生性肾炎临床特征的比较()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年16期
页码:
95-96
栏目:
临床研究
出版日期:
2019-08-15

文章信息/Info

Title:
Comparison of Clinical Features between IgA Nephropathy and Mesangial Proliferative Nephritis
文章编号:
1006-1959(2019)16-0095-02
作者:
刘 枫
大庆油田总医院血液透析室,黑龙江 大庆 163001
Author(s):
LIU Feng
Department of Hemodialysis,Daqing Oilfield General Hospital,Daqing 163001,Heilongjiang,China
关键词:
IgA肾病系膜增生性肾小球肾炎胆固醇尿蛋白IgGIgA
Keywords:
Key words:IgA nephropathyMesangial proliferative glomerulonephritisCholesterolUrine proteinIgGIgA
分类号:
R692.31
DOI:
10.3969/j.issn.1006-1959.2019.16.029
文献标志码:
A
摘要:
目的 比较IgA肾病与系膜增生性肾炎的临床特征。方法 选取2018年1月~2019年3月在我院肾内科就诊的32例IgA肾病患者设为观察1组,将32例系膜增生性肾小球肾炎患者设为观察2组,比较两组患者的年龄、临床表现(水肿、血尿、血压升高)和辅助检查指标(胆固醇、尿蛋白、IgG、IgA)。结果 观察1组患者年龄<25岁的比例高于观察2组(56.25% vs 37.50%),观察2组患者年龄为45~65岁的比例高于观察1组(34.37% vs 12.50%),差异均有统计学意义(P<0.05)。观察1组患者水肿症状的比例低于观察2组(18.75% vs 50.00%),血尿、血压升高的比例高于观察2组(43.75% vs 21.87%,37.50% vs 28.13%),差异均有统计学意义(P<0.05)。观察1组尿蛋白、胆固醇水平低于观察2组,IgG、IgA水平高于观察2组,差异具有统计学意义(P<0.05)。结论 与系膜增生性肾小球肾炎比较,IgA肾病发病年龄更小,主要表现为血尿和血压升高,系膜增生性肾小球肾炎中年发病较多,主要表现为水肿、高胆固醇,研究结果对临床分辨两种疾病具有一定意义。
Abstract:
Abstract:Objective To compare the clinical features of IgA nephropathy with mesangial proliferative nephritis.Methods From January 2018 to March 2019, 32 patients with IgA nephropathy in our department of nephrology were enrolled in the observation group one. 32 patients with mesangial proliferative glomerulonephritis were observation group two. Comparing the two groups about the patient's age, clinical manifestations (edema, hematuria, elevated blood pressure) and auxiliary examination indicators (cholesterol, urine protein, IgG, IgA).Results The proportion of patients <25 years old in observation group 1 was higher than that in observation group 2 (56.25% vs 37.50%). The proportion of patients aged 45-65 years old in observation group 2 was higher than that of observation group 1 (34.37% vs 12.50%),the differences were statistically significant (P<0.05). The proportion of edema symptoms in observation group 1 was lower than that in observation group 2 (18.75% vs 50.00%). The proportion of hematuria and blood pressure was higher than that of observation group 2 (43.75% vs 21.87%, 37.50% vs 28.13%),the differences were statistically significant (P<0.05). The level of urinary protein and cholesterol in observation group 1 was lower than that in observation group 2, and the levels of IgG and IgA were higher than those in observation group 2,the differences were statistically significant (P<0.05).Conclusion Compared with mesangial proliferative glomerulonephritis, the age of onset of IgA nephropathy is smaller, mainly due to elevated hematuria and blood pressure. Mesangial proliferative glomerulonephritis is more common in middle age, mainly characterized by edema and high cholesterol. The results of the study have certain significance for clinically distinguishing between the two diseases.

参考文献/References:

[1]胡显芳.IgA肾病与系膜增生性肾小球肾炎临床特征的比较[J].当代医药论丛,2017,15(4):64-65. [2]徐小蒙,祝爽爽,王晓红,等.系膜区IgG沉积对IgA肾病临床及病理影响[J].南方医科大学学报,2017,37(3):308-311. [3]林新春,张颖,胡瑞敏,等.膜性肾病伴IgA肾病的临床病理特征及预后分析[J].中华实用诊断与治疗杂志,2017,31(7):660-664. [4]喻敏,张伟文,刘春雅,等.431例肾活检病理类型及流行病学特点[J].中国现代医生,2015,53(35):18-21. [5]刘旭,张启东,姜群,等.肾病综合征1077例肾脏活检病理分析[J].临床和实验医学杂志,2017,16(18):1783-1786.

相似文献/References:

[1]陈 越,彭 莉.黄芪对细胞毒素相关蛋白A诱导的大鼠系膜细胞外基质分泌的影响[J].医学信息,2022,35(15):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
 CHEN Yue,PENG Li.Effect of Astragalus Membranaceus on CagA-induced Extracellular Matrix Secretion of Rat Mesangial Cells[J].Journal of Medical Information,2022,35(16):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
[2]黄 婷,张亚莉,李 燕,等.不同性别IgA肾病患者相关临床指标及病理特点对比[J].医学信息,2019,32(21):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
 HUANG Ting,ZHANG Ya-li,LI Yan,et al.Comparative Analysis of Clinical and Pathological Features of Patients with Different Sex IgA Nephropathy[J].Journal of Medical Information,2019,32(16):125.[doi:10.3969/j.issn.1006-1959.2019.21.040]
[3]刘永芳,王 莹.付义主任治疗IgA肾病经验[J].医学信息,2020,33(21):155.[doi:10.3969/j.issn.1006-1959.2020.21.048]
[4]郑桌龙,林 钢,罗勉那,等.成人IgA肾病免疫抑制治疗的研究进展[J].医学信息,2023,36(14):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
 ZHENG Zhuo-long,LIN Gang,LUO Mian-na,et al.Research Progress on Immunosuppressive Therapy for IgA Nephropathy in Adults[J].Journal of Medical Information,2023,36(16):183.[doi:10.3969/j.issn.1006-1959.2023.14.040]
[5]袁茜宁,董怡晨,卿玲玲,等.不同蛋白尿水平IgA肾病患者的临床及病理特征分析[J].医学信息,2024,37(08):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]
 YUAN Qian-ning,DONG Yi-chen,QING Ling-ling,et al.Analysis of Clinical and Pathological Characteristics of IgA Nephropathy Patients with Different Proteinuria Levels[J].Journal of Medical Information,2024,37(16):104.[doi:10.3969/j.issn.1006-1959.2024.08.020]

更新日期/Last Update: 2019-08-15